Provided by Tiger Trade Technology Pte. Ltd.

Invesco S&P SmallCap Health Care ETF

55.75
+0.05000.09%
Volume:3K
Turnover:164.76K
Market Cap:190.67M
PE:- -
High:55.81
Open:55.51
Low:55.48
Close:55.70
52wk High:56.45
52wk Low:39.08
Shares:3.42M
Float Shares:3.42M
Volume Ratio:0.18
T/O Rate:0.09%
Dividend:0.00
Dividend Rate:0.01%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Molina Health is Maintained at Equal-weight by Wells Fargo

Dow Jones
·
Jul 13

Analysts Offer Insights on Healthcare Companies: Genmab (GMAB), Krystal Biotech (KRYS) and Denali Therapeutics (DNLI)

TIPRANKS
·
Jul 13

Alkermes Plc : TD Cowen Raises Target Price to $57 from $50

THOMSON REUTERS
·
Jul 13

Brightspring Health Svcs Initiated at Buy by Guggenheim

Dow Jones
·
Jul 13

Analysts’ Top Healthcare Picks: Molina Healthcare (MOH), Adicet Bio (ACET)

TIPRANKS
·
Jul 13

Alkermes Price Target Announced at $60.00/share by JP Morgan

Dow Jones
·
Jul 13

Alkermes Says Alixorexton Sustains Wakefulness Gains in Nine-month Narcolepsy Extension Study Interim Analysis

Reuters
·
Jul 13

Alkermes - Alixorexton Generally Well Tolerated at All Doses Tested

THOMSON REUTERS
·
Jul 13

Alkermes - Alixorexton Shows Sustained Improvement on Mwt and ESS at Week 24, Nine Months After First Dose

THOMSON REUTERS
·
Jul 13

Alkermes’ Alixorexton Demonstrated Sustained Improvement in Wakefulness in Adults with Narcolepsy Type 1 and Type 2 in Long-term Extension Study Interim Analysis

THOMSON REUTERS
·
Jul 13

BrightSpring Health initiated with a Buy at Guggenheim

TIPRANKS
·
Jul 13

Bank of America Securities Remains a Sell on Alkermes (ALKS)

TIPRANKS
·
Jul 13

Alkermes Plc : JP Morgan Resumes Coverage with Neutral Rating; Target Price $60

THOMSON REUTERS
·
Jul 13

Krystal Biotech Stock And 2 Biotech Names With Pipeline Catalysts

Simply Wall St.
·
Jul 13

How Investors Are Reacting To Molina Healthcare (MOH) Shifting Russell Style Indices After Illinois Medicaid Win

Simply Wall St.
·
Jul 11

Brightspring Health Services Inc : Jefferies Raises Target Price to $84 from $65

THOMSON REUTERS
·
Jul 10

Is Corcept Therapeutics (CORT) Fully Valued On Its Russell Index Removal?

Simply Wall St.
·
Jul 10

Molina Health is Maintained at Underweight by Barclays

Dow Jones
·
Jul 09

Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS) and Immunome (IMNM)

TIPRANKS
·
Jul 09

Corcept Chief Development Officer William Guyer Disposes of USD 1.87 Million in Common Shares

Reuters
·
Jul 09